These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Efficacy and safety of plasma exchange or immunoadsorption for the treatment of option neuritis in demyelinating diseases: A systematic review and meta-analysis. Zhang J; Fan A; Wei L; Wei S; Xie L; Li M; Zhang W; Liu Q; Yang K Eur J Ophthalmol; 2022 Jul; 32(4):1857-1871. PubMed ID: 34918576 [TBL] [Abstract][Full Text] [Related]
16. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study. Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620 [TBL] [Abstract][Full Text] [Related]
17. Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis. Lipphardt M; Wallbach M; Koziolek MJ J Clin Med; 2020 May; 9(5):. PubMed ID: 32466101 [TBL] [Abstract][Full Text] [Related]
18. Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives. Klingel R; Heibges A; Fassbender C Atheroscler Suppl; 2009 Dec; 10(5):129-32. PubMed ID: 20129391 [TBL] [Abstract][Full Text] [Related]
19. Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases. Dorst J; Fillies F; Dreyhaupt J; Senel M; Tumani H J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899499 [TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate-to-severe relapses of multiple sclerosis. Brochet B; Deloire M; Germain C; Ouallet JC; Wittkop L; Dulau C; Perez P; Thevenot F; De Sèze J; Zéphir H; Vermersch P; Pittion S; Debouverie M; Laplaud DA; Clavelou P; Ruet A J Clin Apher; 2020 Aug; 35(4):281-289. PubMed ID: 32369661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]